Surgalign Holdings (NASDAQ:SRGA) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of $(2.31) by 61.04 percent. This is a 57.14 percent increase over losses of $(2.10) per share from the same period last year. The company reported quarterly sales of $16.75 million which beat the analyst consensus estimate of $14.05 million by 19.20 percent. This is a 18.72 percent decrease over sales of $20.61 million the same period last year.